McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...

The stock's fall snapped a two-day winning streak.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Brookstone Capital Management boosted its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 42.8% in the fourth ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

Park Avenue Securities LLC lessened its position in McKesson Co. (NYSE:MCK – Free Report) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities & ...

Explore the importance of Stoicism in investing, focusing on what we can control, like research quality and decision-making ...

McKesson (MCK) closed the most recent trading day at $585.08, moving +0.57% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.16% for the day.

With a market cap of $74.3 billion, Irving, Texas-based McKesson Corporation (MCK) is a global healthcare services and information technology company. Operating through four key segments - U.S ...

McKesson, which is headquartered in Irving, Texas, operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.